Is Palantir Still a Millionaire-Maker Stock?

Palantir posted first-quarter revenue of $1.63 billion, up 85% year over year, with U.S. commercial revenue rising 133% and a new $300 million USDA contract adding to recent defense and intelligence wins. However, the article argues the stock's $343 billion market cap and roughly 161x trailing earnings leave the shares expensive, especially given political and surveillance-related backlash risks. The piece is broadly constructive on the business but cautious on the stock due to valuation.

Analysis

The market is implicitly pricing PLTR as both a high-growth software compounder and a quasi-strategic defense asset, which is a fragile combination when the multiple is this extended. At ~160x trailing earnings, the stock is no longer trading on product adoption alone; it needs a long runway of margin expansion, sustained government win rates, and zero reputational leakage. That creates an asymmetric setup where any slowdown in commercial seat expansion or procurement cycle slippage can compress the multiple faster than fundamentals can catch up.

The bigger second-order risk is not the current contracts themselves but the optionality they destroy. Heavy concentration in politically sensitive workloads increases the probability of procurement pushback, employee activism at customers, and executive-level scrutiny in future administrations; that can cap enterprise sales conversion even if the core product remains superior. In other words, the same defense and surveillance exposure that helps PLTR win headline deals may reduce the addressable market in large-cap commercial accounts that care about brand and ESG adjacency.

From a relative-value lens, NVDA is the cleaner AI expression because its upside is still more directly tied to capex cycles and model training demand, whereas PLTR is now a sentiment/valuation trade with geopolitical overhang. TSLA is the closest analogy on politicized brand risk: once a company becomes a cultural proxy, fundamentals can remain intact while multiple compression persists for quarters. NFLX is essentially neutral here; it may benefit only indirectly if investors rotate out of expensive AI software into profitable consumer internet with clearer cash-flow visibility.

The contrarian miss is that PLTR may be less vulnerable on revenue than bears expect over the next 6-12 months, because public-sector budgets and internal AI adoption tend to be sticky once embedded. The real bear case is not a collapse in demand but a normalization of growth from extraordinary levels, which is enough to justify a much lower multiple. If growth decelerates even modestly from the current pace, the stock can go sideways to down for a long time even without any operational failure.

Key Decisions for Investors

• Short PLTR into strength or via call spreads on any post-earnings rally; thesis is multiple compression rather than absolute business deterioration, with a 3-6 month horizon and best risk/reward if the stock re-tests recent highs before guidance.
• Pair trade: long NVDA / short PLTR for a cleaner AI-vs-AI expression; NVDA has more direct monetization of AI capex and less headline/regulatory risk, while PLTR is priced for near-perfect execution.
• Avoid initiating new long PLTR at current levels unless using options; if constructive, use defined-risk call spreads 6-9 months out because upside is capped by valuation while downside on sentiment shifts is open-ended.
• Use TSLA as a hedge against politicized-brand factor risk; if the market starts punishing visible political exposure again, TSLA and PLTR can both de-rate, making them useful basket shorts against any broad-quality long book.
• For event-driven investors, wait for a 20-25% drawdown in PLTR or a trailing P/E closer to 50 before considering a long; that would improve the forward return profile enough to justify paying for the growth.